Page last updated: 2024-12-06

sodium azide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Sodium Azide: A cytochrome oxidase inhibitor which is a nitridizing agent and an inhibitor of terminal oxidation. (From Merck Index, 12th ed) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

sodium azide : The sodium salt of hydrogen azide (hydrazoic acid). [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID33557
CHEMBL ID89295
CHEBI ID278547
MeSH IDM0029403

Synonyms (67)

Synonym
AKOS015833396
sodium azide
azidosodium
azide, sodium
26628-22-8
NCGC00090996-01
sodium, azoture de [french]
azoture de sodium [french]
nci-c06462
nemazyd
hydrazoic acid, sodium salt
u-3886
sodium, azoturo di [italian]
natriumazid [german]
rcra waste number p105
natriummazide [dutch]
azydek sodu [polish]
ccris 1261
rcra waste no. p105
hsdb 695
einecs 247-852-1
kazoe
nsc 3072
ai3-50436
caswell no. 744a
un1687
smite
epa pesticide chemical code 107701
nan3
chembl89295 ,
S0489
sodium azide-15n3
1015486-10-8
natriumazid
chebi:278547 ,
azoture de sodium
NCGC00254054-01
NCGC00260010-01
dtxcid80121
dtxsid8020121 ,
cas-26628-22-8
tox21_300024
tox21_202461
AKOS015951264
ec 247-852-1
968jj8c9dv ,
sodium, azoturo di
natriummazide
sodium azide [un1687] [poison]
sodium, azoture de
unii-968jj8c9dv
azydek sodu
sodium trinitride
hydrazoic acid sodium salt
sodium azide [hsdb]
sodium azide [mi]
natrium azide
PXIPVTKHYLBLMZ-UHFFFAOYSA-N
sodium azid
azido sodium
sodium-azide
sodium azid e
J-016500
Q407577
sodium;azide
azide, 2% solution
na n3

Research Excerpts

Overview

Sodium azide is a chemical with a mechanism similar to cyanide. Sodium azide poisonings are a rare reason for hospitalization in toxicological units.

ExcerptReferenceRelevance
"Sodium azide is a commonly used cytochrome oxidase inhibitor that leads to translation repression and RNA granule assembly. "( Elucidation of the RNA-granule inducing sodium azide stress response through transcriptome analysis.
Garg, M; Poornima, G; Rajyaguru, PI, 2020
)
2.27
"Sodium azide is a highly toxic chemical. "( Sodium azide poisoning: a narrative review.
Boss, GR; Golomb, BA; Heskett, K; Pilz, RB; Satomi, S; Tat, J, 2021
)
3.51
"Sodium azide is an old poison with toxicity comparable to potassium cyanide. "( A novel procedure for stabilization of azide in biological samples and method for its determination (HS-GC-FID/FID).
Szpot, P; Wachełko, O; Zawadzki, M, 2021
)
2.06
"Sodium azide (NaN3) is a chemical of rapidly growing commercial importance. "( Neuroprotective effects of hydrogen sulfide on sodium azide‑induced autophagic cell death in PC12 cells.
Chang, P; Chu, Y; Shan, H; Tao, L; Wang, Y; Yang, L; Zhang, M; Zhu, S, 2017
)
2.15
"Sodium azide is a chemical with a mechanism similar to cyanide. "( Multiple poisonings with sodium azide at a local restaurant.
Cantu, G; Chung, WM; Kleinschmidt, KC; Schwarz, ES; Sharma, K; Spargo, E; Todd, E; Wax, PM, 2014
)
2.15
"Sodium azide poisonings are a rare reason for hospitalization in toxicological units. "( [Sodium azide poisoning--a rare reason of hospitalization in toxicological units--case report].
Kostek, H; Kujawa, A; Lewandowska-Stanek, H; Majewska, M; Sawiniec, J; Szponar, J, 2012
)
2.73
"Sodium azide (NaN3) is an inorganic matrix compound with a very high toxicity. "( [Suicidal intoxication with sodium azide--a case report].
Galer-Tatarowicz, K; Jankowski, Z; Krzyzanowski, M; Sein Anand, J; Wiergowski, M, 2012
)
2.12
"Sodium azide (NaN3) is a special inhibitor of mitochondrion cytochrome c oxidase (COX), which can be used to mimic neuronal damage induced by mitochondrial deficiency."( [Changes of thioredoxin mRNA level in neurons with mitochondrial dysfunction insulted by H2O2].
Gao, J; Lu, SY; Xu, JY; Xu, L; Zhang, TT; Zou, Y, 2004
)
1.04
"Sodium azide (NaN3) is a specific inhibitor of mitochondrial cytochrome c oxidase (COX), which can be used to mimic neuronal damage induced by mitochondrial deficiency."( [Changes of thioredoxin mRNA level in neurons insulted by sodium azide].
Gao, J; Lu, SY; Qin, Y; Wu, HW; Xu, JY; Xu, L; Zhang, TT; Zhao, L, 2002
)
1.28
"Sodium azide is a highly toxic substance. "( Effect of sodium azide on the metabolic activity of cultured fetal cells.
Ishikawa, T; Maeda, H; Zhu, BL, 2006
)
2.18
"Sodium azide is an inhibitor of cytochrome oxidase which produces selective striatal lesions in both rodents and primates. "( Systemic or local administration of azide produces striatal lesions by an energy impairment-induced excitotoxic mechanism.
Beal, MF; Brouillet, E; Henshaw, DR; Hyman, BT; Jenkins, BG; Rosen, BR; Schulz, JB; Sodhi, P, 1994
)
1.73
"Sodium azide (AZ) is a nitrovasodilator with diverse biochemical properties. "( Sodium azide protects against ischemia-induced acute renal failure in rats.
Abrahams, SL; Ayers, KM; Hazen, RJ, 1993
)
3.17
"Sodium azide is a rapidly active, vasodilatory hypotensive agent that causes headaches and drops in blood pressure."( Occupational health data as a basis for process engineering changes: development of a safe work environment in the sodium azide industry.
Cummings, L; Howearth, G; Lamm, SH; Nicoll, PG; Rippen, HE; Thayer, D, 1996
)
1.23
"Sodium azide (NaN3, AZ) is a potent inhibitor and uncoupler of oxidative phosphorylation as well as a nitrovasodilator after being converted to nitric oxide (NO). "( Intratubular application of sodium azide inhibits loop of Henle reabsorption and tubuloglomerular feedback response in anesthetized rats.
Huang, DY; Osswald, H; Vallon, V, 1998
)
2.04
"Sodium azide is a volatile compound used in the industrial setting and it is also a constituent of car airbags."( Sodium azide burn: a case report.
Greenhalgh, DG; Palmieri, TL; Pham, T,
)
2.3
"Sodium azide is a key component in the automobile air bag. "( Adsorption of hydrazoic acid from aqueous solution by macroreticular resin.
Huang, CP; Lin, SH, 2001
)
1.75
"Sodium azide is a chemical of rapidly growing commercial importance with a high acute toxicity and an unknown mechanism of action. "( Acute neurotoxicity of sodium azide and nitric oxide.
Kruszyna, H; Kruszyna, R; Louis, CA; Smith, RP, 1991
)
2.03
"Sodium azide is an uncommon but potent poison which can cause serious illness and death."( Death following accidental sodium azide ingestion.
Case, GA; Howard, JD; Lacsina, EQ; Raisys, VA; Skogerboe, KJ, 1990
)
1.3
"Sodium azide is a potent mutagen of maize (Zea mays L.) kernels that may have potential as a point mutagen for inducing biochemical mutations in maize tissue cultures. "( Differential metabolism of sodium azide in maize callus and germinating embryos.
Dotson, SB; Somers, DA, 1989
)
2.02
"Sodium azide is a strong inhibitor of the tonic component of contraction produced by oxytocin, whereas aminophylline produces almost equal inhibition of all types of activation of the isolated rat uterus. "( Comparative effects of sodium azide and aminophylline on the rat isolated uterus during muscle activation.
Milovanović, SR; Varagić, VM, 1985
)
2.02
"Sodium azide (NaN3) is a highly reactive, toxic, widely used chemical. "( Suicidal sodium azide ingestion.
Abrams, J; el-Mallakh, RS; Meyer, R, 1987
)
2.13

Effects

Sodium azide has been reported in the literature to reduce the release of secreted amyloid beta-precursor protein. It has been evaluated as a preservative for human faeces for subsequent Kato analysis.

ExcerptReferenceRelevance
"Sodium azide has been reported in the literature to reduce the release of secreted amyloid beta-precursor protein (AbetaPPs) and to produce a large increase in the cellular level of an 11.5 kDa C-terminal AbetaPP derivative containing the beta-amyloid (Abeta) sequence. "( Effects of sodium azide on the secretion of soluble amyloid-beta precursor protein and the accumulation of beta-amyloid(1-40) in cultured chick neurons.
Fowler, CJ; Hedin, HL, 2000
)
2.14
"Sodium azide has been evaluated as a preservative for human faeces for subsequent Kato analysis."( Sodium azide preservation of faecal specimens for Kato analysis.
Bundy, DA; Foreman, JD; Golden, MH, 1985
)
2.43

Actions

ExcerptReferenceRelevance
"Sodium azide failed to inhibit CL, indicating a myeloperoxidase-independent mechanism of light emission."( Murine glia cells in culture can be stimulated to generate reactive oxygen.
Fontana, A; Peterhans, E; Schwyzer, M; Sonderer, B; Wild, P; Wyler, R, 1987
)
0.99

Treatment

Sodium azide treatment partially reversed low HTI-286 accumulation, suggesting involvement of an ATP-dependent drug pump. Treatment with sodium azide resulted in cell death in a dose-responsive manner.

ExcerptReferenceRelevance
"Sodium azide treatment partially reversed low HTI-286 accumulation, suggesting involvement of an ATP-dependent drug pump."( Cells resistant to HTI-286 do not overexpress P-glycoprotein but have reduced drug accumulation and a point mutation in alpha-tubulin.
Annable, T; Ayral-Kaloustian, S; Fojo, T; Greenberger, LM; Hari, M; Kaplan, J; Loganzo, F; May, MK; Minnick, AA; Morilla, DB; Musto, S; Poruchynsky, MS; Tan, X; Zask, A, 2004
)
1.04
"Treatment with sodium azide resulted in cell death in a dose-responsive manner."( Temperature increase exacerbates apoptotic neuronal death in chemically-induced ischemia.
He, C; Stroink, A; Vogel, L; Wang, CX, 2013
)
0.73

Toxicity

ExcerptReferenceRelevance
" Thus, this commercially important and widely distributed chemical with high acute toxicity is not considered to be teratogenic in hamsters, and it produces embryotoxicity only at dose rates that result in toxic signs in the dams."( Embryotoxic effects of sodium azide infusions in the Syrian hamster.
Ferm, VH; Kruszyna, H; Kruszyna, R; Sana, TR; Smith, RP; Wilcox, DE, 1990
)
0.59
" The toxic effects of the major basic and cationic proteins were inhibited by the polyanions heparin and dextran sulfate, in keeping with the cationic nature of these proteins, or by heat denaturation, suggesting that molecular conformation was also relevant."( Toxic effects produced or mediated by human eosinophil granule components on Trypanosoma cruzi.
Gleich, GJ; Hamann, KJ; Kierszenbaum, F; Molina, HA, 1988
)
0.27
" As target cell lysis is totally or partially inhibited by catalase, sodium azide and potassium cyanide, an involvement of toxic oxygen derivatives as cytolytic mediators was suggested."( Eosinophil-mediated cellular cytotoxicity induced by zymosan-activated serum.
De Simone, C; Ferrarelli, G; Ferrari, M; Pugnaloni, L; Rumi, C; Sorice, F, 1986
)
0.51
"Humic acid (HA) has been shown to be a toxic factor for many mammalian cells, however the specific mechanism of the cytotoxicity induced by HA remains unclear."( Humic acid mediates iron release from ferritin and promotes lipid peroxidation in vitro: a possible mechanism for humic acid-induced cytotoxicity.
Ho, KJ; Huang, TS; Liu, TK; Lu, FJ, 2003
)
0.32
" Based on the results of this study, the No Observed Adverse Effect Level (NOAEL) and the Lowest Observed Adverse Effect Level (LOAEL) for maternal and developmental toxicity of NaN(3) in rats were considered to be 5 and 17."( Maternal and developmental toxicity study of sodium azide in rats.
Faqi, AS; Hauswirth, JW; Richards, D; Schroeder, R, 2008
)
0.61
" Potassium cyanide, a Cu,Zn-superoxide dismutase inhibitor, abolishes the toxic effect of Abeta(25-35) to erythrocytes, whereas mercaptosuccinate, a glutathione peroxidase inhibitor, and ouabain, a Na+,K+-ATPase inhibitor, promote it."( [Role of glycolysis and antioxidant enzymes in the toxicity of amyloid beta peptide Abeta25-35 to erythrocytes].
Kaminskiĭ, IuG; Kosenko, EA; Marov, NV; Pogosian, AS; Solomadin, IN; Venediktova, NI,
)
0.13
" Neutral red uptake showed that ascorbate, but not dehydroascorbate, was highly toxic in the MMe cell lines REN and MM98, and less toxic in immortalized (human mesothelial cells-htert) and primary mesothelial cells."( Selective ascorbate toxicity in malignant mesothelioma: a redox Trojan mechanism.
Biffo, S; Burlando, B; Ranzato, E, 2011
)
0.37
" Given that evaluating genetic toxicology tests is essential in investigating the safe use and chemopreventive potential of different natural and synthetic compounds, this study aimed to assess the genotoxic, cytotoxic, antigenotoxic, and anticytotoxic activity of the chalcone 1E,4E-1-(4-chlorophenyl)-5-(2,6,6-trimethylcyclohexen-1-yl)penta-1,4-dien-3-one (CAB7β)."( Presence of antigenotoxic and anticytotoxic effects of the chalcone 1E,4E-1-(4-chlorophenyl)-5-(2,6,6-trimethylcyclohexen-1-yl)penta-1,4-dien-3-one using in vitro and in vivo assays.
Chen-Chen, L; da Silva Junior, NJ; de Melo Reis, PR; eSilva, CR; Lemes, SR; Lima, RS; Montes de Sousa, MA; Perez, CN; Véras, JH, 2020
)
0.56

Pharmacokinetics

ExcerptReferenceRelevance
" In pharmacokinetic studies, HL-60/AR cells exposed to different extracellular concentrations of [14C]DNR consistently accumulated less radioactive drug than the parent HL-60 cells."( Intracellular distribution and pharmacokinetics of daunorubicin in anthracycline-sensitive and -resistant HL-60 cells.
Baker, MA; Bhalla, K; Gervasoni, JE; Hindenburg, AA; Krishna, S; Lutzky, J; Rosado, M; Stewart, VJ; Taub, RN, 1989
)
0.28

Compound-Compound Interactions

ExcerptReferenceRelevance
" Binding of the 2E9-gold complex is followed by internalization, as judged from Nanovid light microscopy studies in combination with electron microscopic observations."( Dynamics of epidermal growth factor receptor internalization studied by Nanovid light microscopy and electron microscopy in combination with immunogold labeling.
Boonstra, J; de Brabander, M; Defize, LH; Nuijdens, R; van 't Hof, RJ; Verkleij, AJ, 1989
)
0.28

Bioavailability

ExcerptReferenceRelevance
"Oral bioavailability for antisense oligonucleotides has recently been reported but the mechanistic details are not known."( Interactions of phosphodiester and phosphorothioate oligonucleotides with intestinal epithelial Caco-2 cells.
Akhtar, S; Beck, GF; Irwin, WJ; Nicklin, PL, 1996
)
0.29
" The in vivo bioavailability for 24-h application in humans was 45."( Human in vivo and in vitro hydroquinone topical bioavailability, metabolism, and disposition.
Cox, R; Hui, X; Maibach, HI; Melendres, J; Quan, D; Serranzana, S; Wester, RC; Zhai, H, 1998
)
0.3
" The potential of ODNs for modulating liver-specific genes might be increased by preventing untimely elimination and by improving the local bioavailability of ODNs in the target tissue."( Targeted delivery of oligodeoxynucleotides to parenchymal liver cells in vivo.
Biessen, EA; Bijsterbosch, MK; Fluiter, K; Kuiper, J; Rump, ET; van Berkel, TJ; Vietsch, H, 1999
)
0.3
" Since typical substrates for intestinal carriers are hydrophilic and charged, the involvement of putative absorptive carriers in the transport of CPT is a novel finding that may give insight into the erratic oral bioavailability of CPTs observed in the clinic."( The intestinal absorption of camptothecin, a highly lipophilic drug, across Caco-2 cells is mediated by active transporter(s).
Gupta, E; Lallo, A; Luo, F; Ramanathan, S; Rubin, E; Sinko, P; Vyas, V,
)
0.13
" This leads to a secretion-limited peroral absorption of salbutamol, which contributes to the poor oral bioavailability of the drug."( The influence of active secretion processes on intestinal absorption of salbutamol in the rat.
Casabó, VG; Martín-Villodre, A; Nácher, A; Valenzuela, B, 2001
)
0.31
" Growth on PAHs cannot easily be determined with standard growth assays because of the very low aqueous solubility and bioavailability of the PAHs."( Detection of microbial growth on polycyclic aromatic hydrocarbons in microtiter plates by using the respiration indicator WST-1.
Bendixen, K; Johnsen, AR; Karlson, U, 2002
)
0.31
" The transport system in the rat model was ATP-dependent, as sodium azide was able to decrease the absorption rate constant in a concentration-dependent fashion."( Kinetic modelling of the intestinal transport of sarafloxacin. Studies in situ in rat and in vitro in Caco-2 cells.
Bermejo, M; Casabó, VG; Fernandez-Teruel, C; Gonzalez-Alvarez, I; Ruiz-Garcia, A, 2005
)
0.57
" Furthermore, these compounds distributed to target tissues (liver and spleen) and had a moderate oral bioavailability (up to 25%), a large volume of distribution, and an elimination half-life ranging from 1 to 2 days in mice."( Novel arylimidamides for treatment of visceral leishmaniasis.
Boykin, DW; Hall, JE; Kyle, DE; Liu, Q; Madhubala, R; Mandal, S; Munde, M; Pandharkar, T; Parman, T; Riccio, E; Srivastava, A; Stephens, CE; Sweat, JM; Tidwell, RR; Wang, MZ; Werbovetz, KA; Wilson, WD; Zhu, X, 2010
)
0.36

Dosage Studied

ExcerptRelevanceReference
" In mice pre-transplanted with EL-4 cells, T-2-mAb increased the mean survival time (MST) with a direct dosage dependence."( Antitumor activity of T-2 toxin-conjugated monoclonal antibody to murine thymoma.
Chiba, J; Kawamura, O; Murakami, H; Ohi, K; Ohtani, K; Otokawa, M; Shibuya, O; Ueno, Y, 1990
)
0.28
" Five of six chemicals tested yielded statistically significant and generally linear dose-response curves."( Assay of mutagens in aqueous fecal extracts with a modified ames Salmonella test.
Andrews, AW; Riggs, CW; Shaw, R, 1985
)
0.27
" This increase was not due to a shift in the PMA dose-response curve, a change in the time course of the PMA response, or an effect of decreased cell density on the assay system."( Exposure to gamma-irradiation increases phorbol myristate acetate-induced H2O2 production in human macrophages.
Gallin, EK; Green, SW, 1987
)
0.27
" A clear dose-response relationship to fractional survival was observed for individual tumors tested at multiple dose levels of abrin."( Usefulness of abrin as a positive control for the human tumor clonogenic assay.
Hayes, C; Liu, R; Persaud, J; Roberts, R; Salmon, SE, 1983
)
0.27
" MH yielded positive responses in all laboratories but no linear dose-response pattern was observed."( Tradescantia stamen hair mutation bioassay.
Cabrera, GL; Cebulska-Wasilewska, A; Chen, R; Loarca, F; Ma, TH; Salamone, MF; Vandenberg, AL, 1994
)
0.29
" The ADP dosage was performed by using a spectrophotometric enzymatic assay."( An in vitro method for evaluating vascular endothelial ADPase activity.
Caprino, L; Stella, C; Togna, AR; Togna, G, 1996
)
0.29
" Seven oral doses of the toxicant, ranging in dosage from 12."( [Neurotoxicity in sodium azide poisoning].
Fujimura, T; Hara, S; Kobayashi, H; Sato, I; Suzuki, T, 2002
)
0.65
" These studies have implications for understanding the brain mechanisms involved in mediating the ascending limb of the biphasic dose-response curve for the effect of ethanol on locomotor activity."( Motor stimulant effects of ethanol injected into the substantia nigra pars reticulata: importance of catalase-mediated metabolism and the role of acetaldehyde.
Aragon, CM; Arizzi-LaFrance, MN; Correa, M; Salamone, JD, 2006
)
0.33
" Luminescence of the A16 strain (luxE mutant) increased significantly after a few hours of such a treatment with various mutagenic agents, revealing a dose-response correlation."( A modified Vibrio harveyi mutagenicity assay based on bioluminescence induction.
Podgórska, B; Wegrzyn, G, 2006
)
0.33
" harveyi mutagenicity assay is rapid, sensitive and reveals a dose-response correlation for various mutagens."( A modified Vibrio harveyi mutagenicity assay based on bioluminescence induction.
Podgórska, B; Wegrzyn, G, 2006
)
0.33
" The dose-response information for these metabolic regulators is crucial for designing future experiments."( Metabolic regulation of in-vitro-produced bovine embryos. I. Effects of metabolic regulators at different glucose concentrations with embryos produced by semen from different bulls.
De La Torre-Sanchez, JF; Preis, K; Seidel, GE, 2006
)
0.33
" It was nongenotoxic in an Ames assay, an in vitro micronucleus assay, and an in vivo rat micronucleus assay when dosed orally up to 2000 mg/kg."( Benzoxaborole Antimalarial Agents. Part 5. Lead Optimization of Novel Amide Pyrazinyloxy Benzoxaboroles and Identification of a Preclinical Candidate.
Berry, P; Campo, B; Cao, J; Ciaravino, V; Easom, EE; Erve, JCL; Freund, YR; Gamo, FJ; Guo, D; Jacobs, RT; Plattner, JJ; Rosenthal, PJ; Sanz, LM; Zhang, YK, 2017
)
0.46
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (4)

RoleDescription
mutagenAn agent that increases the frequency of mutations above the normal background level, usually by interacting directly with DNA and causing it damage, including base substitution.
antibacterial agentA substance (or active part thereof) that kills or slows the growth of bacteria.
explosiveA substance capable of undergoing rapid and highly exothermic decomposition.
mitochondrial respiratory-chain inhibitornull
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
inorganic sodium salt
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (28)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, TYROSYL-DNA PHOSPHODIESTERASEHomo sapiens (human)Potency25.11890.004023.8416100.0000AID485290
acetylcholinesteraseHomo sapiens (human)Potency43.32480.002541.796015,848.9004AID1347395
AR proteinHomo sapiens (human)Potency36.84410.000221.22318,912.5098AID1259243; AID743042; AID743054
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency17.78280.011212.4002100.0000AID1030
thyroid stimulating hormone receptorHomo sapiens (human)Potency5.01190.001318.074339.8107AID926; AID938
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency36.24280.000657.913322,387.1992AID1259377; AID1259394
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency40.82490.001022.650876.6163AID1224838; AID1224839; AID1224893
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency28.54940.003041.611522,387.1992AID1159552; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency5.08480.000817.505159.3239AID1159527; AID1159531
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency53.80200.001530.607315,848.9004AID1224841; AID1224848; AID1224849; AID1259403
farnesoid X nuclear receptorHomo sapiens (human)Potency28.18380.375827.485161.6524AID588527
pregnane X nuclear receptorHomo sapiens (human)Potency121.97200.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency38.83050.000229.305416,493.5996AID1259244; AID1259248; AID1259383; AID743069; AID743075; AID743080; AID743091
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency65.50820.000627.21521,122.0200AID743202; AID743219
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency7.44190.001557.789015,848.9004AID1259244
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency7.44190.001551.739315,848.9004AID1259244
Nuclear receptor ROR-gammaHomo sapiens (human)Potency0.05310.026622.448266.8242AID651802
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Carbonic anhydrase Astrosclera willeyanaKi27,800.00000.03201.51729.6000AID647373
Laccase Trametes versicolorIC50 (µMol)266.33334.70005.13335.8000AID628706; AID628708; AID628709
Carbonic anhydrase 1Homo sapiens (human)Ki1.20000.00001.372610.0000AID1161930; AID552171; AID587130; AID598726; AID714401; AID724722; AID730754; AID763569
Carbonic anhydrase 2Homo sapiens (human)Ki1,505.00000.00000.72369.9200AID1058395; AID1070020; AID1161931; AID1161950; AID1235241; AID1237475; AID1336557; AID1430526; AID1461934; AID552172; AID587131; AID598728; AID714400; AID724721; AID730373; AID730753; AID758952; AID763568
Carbonic anhydrase 4Homo sapiens (human)Ki65,100.00000.00021.97209.9200AID552173
Mu-type opioid receptorRattus norvegicus (Norway rat)Ki1,510.00000.00000.38458.6000AID1161931
Carbonic anhydrase 5A, mitochondrialHomo sapiens (human)Ki300.00000.00001.27259.9000AID552169
Carbonic anhydraseMethanosarcina thermophilaKi5,800.00000.06000.97148.5000AID1235242; AID1336558; AID758950
Carbonic anhydrase 9Homo sapiens (human)Ki5.00000.00010.78749.9000AID552168
Integrase Human immunodeficiency virus 1IC50 (µMol)23,000.60000.00051.544310.0000AID569226; AID684672
Carbonic anhydrase Pseudomonas aeruginosa PAO1Ki770.00000.07596.26909.0000AID1237477
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (29)

Processvia Protein(s)Taxonomy
one-carbon metabolic processCarbonic anhydrase 1Homo sapiens (human)
morphogenesis of an epitheliumCarbonic anhydrase 2Homo sapiens (human)
positive regulation of synaptic transmission, GABAergicCarbonic anhydrase 2Homo sapiens (human)
positive regulation of cellular pH reductionCarbonic anhydrase 2Homo sapiens (human)
angiotensin-activated signaling pathwayCarbonic anhydrase 2Homo sapiens (human)
regulation of monoatomic anion transportCarbonic anhydrase 2Homo sapiens (human)
secretionCarbonic anhydrase 2Homo sapiens (human)
regulation of intracellular pHCarbonic anhydrase 2Homo sapiens (human)
neuron cellular homeostasisCarbonic anhydrase 2Homo sapiens (human)
positive regulation of dipeptide transmembrane transportCarbonic anhydrase 2Homo sapiens (human)
regulation of chloride transportCarbonic anhydrase 2Homo sapiens (human)
carbon dioxide transportCarbonic anhydrase 2Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 2Homo sapiens (human)
bicarbonate transportCarbonic anhydrase 4Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 4Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 5A, mitochondrialHomo sapiens (human)
negative regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
xenobiotic metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of glucose metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of steroid metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
intracellular receptor signaling pathwayNuclear receptor ROR-gammaHomo sapiens (human)
circadian regulation of gene expressionNuclear receptor ROR-gammaHomo sapiens (human)
cellular response to sterolNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of circadian rhythmNuclear receptor ROR-gammaHomo sapiens (human)
regulation of fat cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of DNA-templated transcriptionNuclear receptor ROR-gammaHomo sapiens (human)
adipose tissue developmentNuclear receptor ROR-gammaHomo sapiens (human)
T-helper 17 cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
response to hypoxiaCarbonic anhydrase 9Homo sapiens (human)
morphogenesis of an epitheliumCarbonic anhydrase 9Homo sapiens (human)
response to xenobiotic stimulusCarbonic anhydrase 9Homo sapiens (human)
response to testosteroneCarbonic anhydrase 9Homo sapiens (human)
secretionCarbonic anhydrase 9Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 9Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (15)

Processvia Protein(s)Taxonomy
arylesterase activityCarbonic anhydrase 1Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 1Homo sapiens (human)
protein bindingCarbonic anhydrase 1Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 1Homo sapiens (human)
hydro-lyase activityCarbonic anhydrase 1Homo sapiens (human)
cyanamide hydratase activityCarbonic anhydrase 1Homo sapiens (human)
arylesterase activityCarbonic anhydrase 2Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 2Homo sapiens (human)
protein bindingCarbonic anhydrase 2Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 2Homo sapiens (human)
cyanamide hydratase activityCarbonic anhydrase 2Homo sapiens (human)
protein bindingCarbonic anhydrase 4Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 4Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 4Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 5A, mitochondrialHomo sapiens (human)
zinc ion bindingCarbonic anhydrase 5A, mitochondrialHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
protein bindingNuclear receptor ROR-gammaHomo sapiens (human)
oxysterol bindingNuclear receptor ROR-gammaHomo sapiens (human)
zinc ion bindingNuclear receptor ROR-gammaHomo sapiens (human)
ligand-activated transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
sequence-specific double-stranded DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
nuclear receptor activityNuclear receptor ROR-gammaHomo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 9Homo sapiens (human)
protein bindingCarbonic anhydrase 9Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 9Homo sapiens (human)
molecular function activator activityCarbonic anhydrase 9Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (27)

Processvia Protein(s)Taxonomy
cytosolCarbonic anhydrase 1Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 1Homo sapiens (human)
cytoplasmCarbonic anhydrase 2Homo sapiens (human)
cytosolCarbonic anhydrase 2Homo sapiens (human)
plasma membraneCarbonic anhydrase 2Homo sapiens (human)
myelin sheathCarbonic anhydrase 2Homo sapiens (human)
apical part of cellCarbonic anhydrase 2Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 2Homo sapiens (human)
cytoplasmCarbonic anhydrase 2Homo sapiens (human)
plasma membraneCarbonic anhydrase 2Homo sapiens (human)
apical part of cellCarbonic anhydrase 2Homo sapiens (human)
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
basolateral plasma membraneCarbonic anhydrase 4Homo sapiens (human)
rough endoplasmic reticulumCarbonic anhydrase 4Homo sapiens (human)
endoplasmic reticulum-Golgi intermediate compartmentCarbonic anhydrase 4Homo sapiens (human)
Golgi apparatusCarbonic anhydrase 4Homo sapiens (human)
trans-Golgi networkCarbonic anhydrase 4Homo sapiens (human)
plasma membraneCarbonic anhydrase 4Homo sapiens (human)
external side of plasma membraneCarbonic anhydrase 4Homo sapiens (human)
cell surfaceCarbonic anhydrase 4Homo sapiens (human)
membraneCarbonic anhydrase 4Homo sapiens (human)
apical plasma membraneCarbonic anhydrase 4Homo sapiens (human)
transport vesicle membraneCarbonic anhydrase 4Homo sapiens (human)
secretory granule membraneCarbonic anhydrase 4Homo sapiens (human)
brush border membraneCarbonic anhydrase 4Homo sapiens (human)
perinuclear region of cytoplasmCarbonic anhydrase 4Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 4Homo sapiens (human)
plasma membraneCarbonic anhydrase 4Homo sapiens (human)
mitochondrial matrixCarbonic anhydrase 5A, mitochondrialHomo sapiens (human)
mitochondrionCarbonic anhydrase 5A, mitochondrialHomo sapiens (human)
cytoplasmCarbonic anhydrase 5A, mitochondrialHomo sapiens (human)
mitochondrionCarbonic anhydrase 5A, mitochondrialHomo sapiens (human)
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
nucleoplasmNuclear receptor ROR-gammaHomo sapiens (human)
nuclear bodyNuclear receptor ROR-gammaHomo sapiens (human)
chromatinNuclear receptor ROR-gammaHomo sapiens (human)
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
nucleolusCarbonic anhydrase 9Homo sapiens (human)
plasma membraneCarbonic anhydrase 9Homo sapiens (human)
membraneCarbonic anhydrase 9Homo sapiens (human)
basolateral plasma membraneCarbonic anhydrase 9Homo sapiens (human)
microvillus membraneCarbonic anhydrase 9Homo sapiens (human)
plasma membraneCarbonic anhydrase 9Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (117)

Assay IDTitleYearJournalArticle
AID552173Inhibition of human carbonic anhydrase 4 by Lineweaver-Burk curves2011Bioorganic & medicinal chemistry, Jan-15, Volume: 19, Issue:2
Characterization and anions inhibition studies of an α-carbonic anhydrase from the teleost fish Dicentrarchus labrax.
AID1103923Inhibition of cytochrome c oxidase in insecticide-susceptible Drosophila melanogaster Canton-S mitochondria using reduced cytochrome c as substrate by microplate spectrophotometer analysis2009Pest management science, Jun, Volume: 65, Issue:6
Mitochondrial impacts of insecticidal formate esters in insecticide-resistant and insecticide-susceptible Drosophila melanogaster.
AID684672Inhibition of HIV-1 integrase by colorimetry2012Journal of natural products, Aug-24, Volume: 75, Issue:8
Thiazoline peptides and a tris-phenethyl urea from Didemnum molle with anti-HIV activity.
AID758948Inhibition of Porphyromonas gingivalis recombinant CA by CO2 hydration assay2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
A highly catalytically active γ-carbonic anhydrase from the pathogenic anaerobe Porphyromonas gingivalis and its inhibition profile with anions and small molecules.
AID677271Inhibition of Helicobacter pylori alpha-carbonic anhydrase-catalyzed CO2 hydration reaction preincubated for 15 mins by stopped flow CO2 hydrase assay2012Bioorganic & medicinal chemistry letters, Sep-01, Volume: 22, Issue:17
Anion inhibition studies of an α-carbonic anhydrase from the thermophilic bacterium Sulfurihydrogenibium yellowstonense YO3AOP1.
AID323190Protection against 30 mins photoirradiation-induced damage in rat liver mitochondria assessed as reduction of lipid hydroperoxide formation at 10 mM2008Bioorganic & medicinal chemistry, Mar-15, Volume: 16, Issue:6
Inhibitory property of the Piper betel phenolics against photosensitization-induced biological damages.
AID1179428Genotoxicity in Salmonella typhimurium TA100 at 1.25 ug/plate assessed as number of revertants per plate (Rvb = 136.8 +/- 3.4 no unit)2014Bioorganic & medicinal chemistry letters, Jul-15, Volume: 24, Issue:14
Synthesis and evaluation of novel dapsone-thalidomide hybrids for the treatment of type 2 leprosy reactions.
AID763568Inhibition of human carbonic anhydrase-2 at 20 degC preincubated for 15 mins by stopped-flow CO2 hydrase assay2013Bioorganic & medicinal chemistry, Aug-01, Volume: 21, Issue:15
Anion inhibition studies of the α-carbonic anhydrase from the protozoan pathogen Trypanosoma cruzi, the causative agent of Chagas disease.
AID1577412Genotoxicity in Salmonella typhimurium TA98 at 30 uM in absence of rat liver S9 fraction by Ames test2019Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
Development of 3,5-Dinitrophenyl-Containing 1,2,4-Triazoles and Their Trifluoromethyl Analogues as Highly Efficient Antitubercular Agents Inhibiting Decaprenylphosphoryl-β-d-ribofuranose 2'-Oxidase.
AID552169Inhibition of human carbonic anhydrase 5 by Lineweaver-Burk curves2011Bioorganic & medicinal chemistry, Jan-15, Volume: 19, Issue:2
Characterization and anions inhibition studies of an α-carbonic anhydrase from the teleost fish Dicentrarchus labrax.
AID714401Inhibition of human cytosolic carbonic anhydrase 1 preincubated for 15 mins by stopped flow CO2 hydration assay2012Bioorganic & medicinal chemistry letters, Dec-01, Volume: 22, Issue:23
Anion inhibition studies of the fastest carbonic anhydrase (CA) known, the extremo-CA from the bacterium Sulfurihydrogenibium azorense.
AID730373Inhibition of human cytosolic carbonic anhydrase-2 preincubated for 15 mins by stopped flow CO2 hydration assay2013Bioorganic & medicinal chemistry letters, Mar-15, Volume: 23, Issue:6
Kinetic and anion inhibition studies of a β-carbonic anhydrase (FbiCA 1) from the C4 plant Flaveria bidentis.
AID598728Inhibition of recombinant human carbonic anhydrase 2 after 15 mins by stopped flow CO2 hydration assay at pH 8.32011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
Inhibition studies with anions and small molecules of two novel β-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium.
AID724721Inhibition of human recombinant wild type CA2 by stopped-flow CO2 hydration method2013Bioorganic & medicinal chemistry letters, Jan-01, Volume: 23, Issue:1
Restoring catalytic activity to the human carbonic anhydrase (CA) related proteins VIII, X and XI affords isoforms with high catalytic efficiency and susceptibility to anion inhibition.
AID763567Inhibition of Brucella suis beta carbonic anhydrase-1 at 20 degC by stopped-flow CO2 hydrase assay2013Bioorganic & medicinal chemistry, Aug-01, Volume: 21, Issue:15
Anion inhibition studies of the α-carbonic anhydrase from the protozoan pathogen Trypanosoma cruzi, the causative agent of Chagas disease.
AID278887Increase in lactate production in MG63 cells at 1mM after 1 hr by ELISA2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
AID763565Inhibition of recombinant Trypanosoma cruzi CL Brener alpha carbonic anhydrase expressed in baculovirus infected SF9 cells at 20 degC preincubated for 15 mins by stopped-flow CO2 hydrase assay2013Bioorganic & medicinal chemistry, Aug-01, Volume: 21, Issue:15
Anion inhibition studies of the α-carbonic anhydrase from the protozoan pathogen Trypanosoma cruzi, the causative agent of Chagas disease.
AID1235244Inhibition of Nostoc commune CA after 15 mins by stopped-flow/Co2 hydration assay2015Bioorganic & medicinal chemistry, Aug-01, Volume: 23, Issue:15
Cloning, characterization and anion inhibition studies of a new γ-carbonic anhydrase from the Antarctic bacterium Pseudoalteromonas haloplanktis.
AID471636Cytotoxicity against human HEK293 cells at 30 mM after 48 hrs by neutral red assay2009European journal of medicinal chemistry, Dec, Volume: 44, Issue:12
Synthesis and serotonin transporter activity of sulphur-substituted alpha-alkyl phenethylamines as a new class of anticancer agents.
AID1235245Inhibition of Pseudoalteromonas haloplanktis gamma-CA after 15 mins by stopped-flow/Co2 hydration assay2015Bioorganic & medicinal chemistry, Aug-01, Volume: 23, Issue:15
Cloning, characterization and anion inhibition studies of a new γ-carbonic anhydrase from the Antarctic bacterium Pseudoalteromonas haloplanktis.
AID1265552Mutagenicity in Salmonella typhimurium TA1535 assessed as number of revertants at 5 ug/plate by Ames test (Rvb = 10 +/- 3 No_unit)2016European journal of medicinal chemistry, Jan-01, Volume: 107Anticonvulsant activity, crystal structures, and preliminary safety evaluation of N-trans-cinnamoyl derivatives of selected (un)modified aminoalkanols.
AID1312218Inhibition of Plasmodium falciparum full length recombinant His-fused Eta-carbonic anhydrase domain preincubated for 15 mins by stopped-flow CO2 hydrase assay2016Bioorganic & medicinal chemistry, 09-15, Volume: 24, Issue:18
Anion inhibition profiles of the complete domain of the η-carbonic anhydrase from Plasmodium falciparum.
AID1060852Inhibition of HIV1 integrase at 50 uM2014Bioorganic & medicinal chemistry letters, Jan-01, Volume: 24, Issue:1
Synthesis, anti-HIV activity, integrase enzyme inhibition and molecular modeling of catechol, hydroquinone and quinol labdane analogs.
AID552172Inhibition of human carbonic anhydrase 2 by Lineweaver-Burk curves2011Bioorganic & medicinal chemistry, Jan-15, Volume: 19, Issue:2
Characterization and anions inhibition studies of an α-carbonic anhydrase from the teleost fish Dicentrarchus labrax.
AID1161932Inhibition of recombinant Plasmodium falciparum eta-carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration method2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Discovery of a new family of carbonic anhydrases in the malaria pathogen Plasmodium falciparum--the η-carbonic anhydrases.
AID552785Inhibition of Streptococcus pneumoniae beta-carbonic anhydrase after 15 mins by stopped flow CO2 hydration assay2011Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
Inhibition of the β-carbonic anhydrase from Streptococcus pneumoniae by inorganic anions and small molecules: Toward innovative drug design of antiinfectives?
AID1070022Inhibition of Legionella pneumophila carbonic anhydrase 1 preincubated for 15 mins by stopped-flow CO2 hydrase assay2014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Anion inhibition studies of two new β-carbonic anhydrases from the bacterial pathogen Legionella pneumophila.
AID628709Inhibition of Trametes versicolor laccase assessed as production of dopachrome using 300 uM L-dopa as substrate preincubated for 30 mins before substrate addition2011Bioorganic & medicinal chemistry, Nov-15, Volume: 19, Issue:22
Ptilomycalin A inhibits laccase and melanization in Cryptococcus neoformans.
AID587131Inhibition of human carbonic anhydrase 2 after 15 mins by CO2 hydrase assay at pH 7.52011Bioorganic & medicinal chemistry, Mar-15, Volume: 19, Issue:6
Purification and inhibition studies with anions and sulfonamides of an α-carbonic anhydrase from the Antarctic seal Leptonychotes weddellii.
AID1461938Inhibition of recombinant His6-tagged Francisella tularensis beta-CA (227 residues) expressed in Escherichia coli BL21(DE3) incubated for 15 mins by stopped-flow CO2 hydration assay
AID569229Inhibition of HIV1 reverse transcriptase2011Bioorganic & medicinal chemistry, Feb-01, Volume: 19, Issue:3
Design and synthesis of caffeoyl-anilides as portmanteau inhibitors of HIV-1 integrase and CCR5.
AID598732Inhibition of Salmonella Typhimurium carbonic anhydrase 2 after 15 mins by stopped flow CO2 hydration assay at pH 8.32011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
Inhibition studies with anions and small molecules of two novel β-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium.
AID1243825Mutagenicity in Salmonella typhimurium TA100 assessed as mutagenicity index at 5 ug/plate incubated for 90 mins at 37 degC in absence of liver S9 fractions by Ames test relative to control2015European journal of medicinal chemistry, Aug-28, Volume: 101Leishmanicidal, antiproteolytic, and mutagenic evaluation of alkyltriazoles and alkylphosphocholines.
AID1570609Mutagenicity in Salmonella typhimurium TA100 at 5 ug/plate preincubated for 20 mins followed by addition of top agar and measured after 48 hrs by Ames test2019Bioorganic & medicinal chemistry letters, 11-01, Volume: 29, Issue:21
Design, synthesis and evaluation of activity and pharmacokinetic profile of new derivatives of xanthone and piperazine in the central nervous system.
AID1570614Mutagenicity in Salmonella typhimurium TA98 at 5 ug/plate preincubated for 20 mins followed by addition of top agar and measured after 48 hrs by Ames test2019Bioorganic & medicinal chemistry letters, 11-01, Volume: 29, Issue:21
Design, synthesis and evaluation of activity and pharmacokinetic profile of new derivatives of xanthone and piperazine in the central nervous system.
AID1060851Inhibition of HIV1 integrase2014Bioorganic & medicinal chemistry letters, Jan-01, Volume: 24, Issue:1
Synthesis, anti-HIV activity, integrase enzyme inhibition and molecular modeling of catechol, hydroquinone and quinol labdane analogs.
AID1103922Inhibition of cytochrome c oxidase in insecticide-resistance Drosophila melanogaster Hikone-R mitochondria using reduced cytochrome c as substrate by microplate spectrophotometer analysis2009Pest management science, Jun, Volume: 65, Issue:6
Mitochondrial impacts of insecticidal formate esters in insecticide-resistant and insecticide-susceptible Drosophila melanogaster.
AID661625Mutagenic activity in Salmonella typhimurium TA 100 assessed as increase in revertants at 5 ug/plate after 48 hrs by Ames test relative to control2012Bioorganic & medicinal chemistry letters, Jun-01, Volume: 22, Issue:11
Synthesis, study on anti-arthritic, anti-inflammatory activity and toxicity of some novel bis-oxy cyclophane diamides.
AID730754Inhibition of human carbonic anhydrase 1 preincubated for 15 mins by stopped flow CO2 hydration assay2013Bioorganic & medicinal chemistry letters, Mar-15, Volume: 23, Issue:6
Anion inhibition studies of the α-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae.
AID1235243Inhibition of Porphyromonas gingivalis CA after 15 mins by stopped-flow/Co2 hydration assay2015Bioorganic & medicinal chemistry, Aug-01, Volume: 23, Issue:15
Cloning, characterization and anion inhibition studies of a new γ-carbonic anhydrase from the Antarctic bacterium Pseudoalteromonas haloplanktis.
AID1336559Inhibition of Porphyromonas gingivalis recombinant carbonic anhydrase gamma assessed as inhibition of CO2 hydration preincubated for 15 mins by Lineweaver-burk plot method
AID587130Inhibition of human carbonic anhydrase 1 after 15 mins by CO2 hydrase assay at pH 7.52011Bioorganic & medicinal chemistry, Mar-15, Volume: 19, Issue:6
Purification and inhibition studies with anions and sulfonamides of an α-carbonic anhydrase from the Antarctic seal Leptonychotes weddellii.
AID1296411Mutagenic activity in Salmonella typhimurium TA100 assessed as reverse mutation at 30 uM by Ames test2016Journal of medicinal chemistry, Mar-24, Volume: 59, Issue:6
Development of 3,5-Dinitrobenzylsulfanyl-1,3,4-oxadiazoles and Thiadiazoles as Selective Antitubercular Agents Active Against Replicating and Nonreplicating Mycobacterium tuberculosis.
AID1461934Inhibition of human CA2 incubated for 15 mins by stopped-flow CO2 hydration assay
AID730752Inhibition of Helicobacter pylori alpha carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration assay2013Bioorganic & medicinal chemistry letters, Mar-15, Volume: 23, Issue:6
Anion inhibition studies of the α-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae.
AID1235242Inhibition of archaeon Methanosarcina thermophila gamma-CA after 15 mins by stopped-flow/Co2 hydration assay2015Bioorganic & medicinal chemistry, Aug-01, Volume: 23, Issue:15
Cloning, characterization and anion inhibition studies of a new γ-carbonic anhydrase from the Antarctic bacterium Pseudoalteromonas haloplanktis.
AID278883Antiproliferative effect against primary human osteoblasts assessed as BrdU incorporation into DNA after 48 hrs after 48 hrs below 1 mM2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
AID628708Inhibition of Trametes versicolor laccase assessed as production of dopachrome using 200 uM dopamine as substrate preincubated for 30 mins before substrate addition2011Bioorganic & medicinal chemistry, Nov-15, Volume: 19, Issue:22
Ptilomycalin A inhibits laccase and melanization in Cryptococcus neoformans.
AID1161930Inhibition of human carbonic anhydrase 1 preincubated for 15 mins by stopped flow CO2 hydration method2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Discovery of a new family of carbonic anhydrases in the malaria pathogen Plasmodium falciparum--the η-carbonic anhydrases.
AID598731Inhibition of Salmonella Typhimurium carbonic anhydrase 1 after 15 mins by stopped flow CO2 hydration assay at pH 8.32011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
Inhibition studies with anions and small molecules of two novel β-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium.
AID1461935Inhibition of Burkholderia pseudomallei beta-CA incubated for 15 mins by stopped-flow CO2 hydration assay
AID1082234Inhibition of Bos taurus (bovine) CAT in liver at 300 microM2011Journal of agricultural and food chemistry, May-11, Volume: 59, Issue:9
Neonicotinoid insecticides: oxidative stress in planta and metallo-oxidase inhibition.
AID1235241Inhibition of human CA2 after 15 mins by stopped-flow/Co2 hydration assay2015Bioorganic & medicinal chemistry, Aug-01, Volume: 23, Issue:15
Cloning, characterization and anion inhibition studies of a new γ-carbonic anhydrase from the Antarctic bacterium Pseudoalteromonas haloplanktis.
AID1336561Inhibition of Pseudoalteromonas haloplanktis recombinant carbonic anhydrase gamma assessed as inhibition of CO2 hydration preincubated for 15 mins by Lineweaver-burk plot method
AID1570619Mutagenicity in Salmonella typhimurium TA102 at 5 ug/plate preincubated for 20 mins followed by addition of top agar and measured after 48 hrs by Ames test2019Bioorganic & medicinal chemistry letters, 11-01, Volume: 29, Issue:21
Design, synthesis and evaluation of activity and pharmacokinetic profile of new derivatives of xanthone and piperazine in the central nervous system.
AID1058389Inhibition of Clostridium perfringens carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration assay2013Bioorganic & medicinal chemistry letters, Dec-15, Volume: 23, Issue:24
Anion inhibition studies of a β-carbonic anhydrase from Clostridium perfringens.
AID1161951Inhibition of Porphyromonas gingivalis gamma-carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration method2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Anion inhibition study of the β-class carbonic anhydrase (PgiCAb) from the oral pathogen Porphyromonas gingivalis.
AID1457269Genotoxicity in Salmonella typhimurium TA1535 assessed as number of revertants per plate at 1 ug/plate in absence of rat liver S9 fraction by Ames test (Rvb = 10 +/- 3 No_unit)2017Journal of medicinal chemistry, 07-13, Volume: 60, Issue:13
Benzoxaborole Antimalarial Agents. Part 5. Lead Optimization of Novel Amide Pyrazinyloxy Benzoxaboroles and Identification of a Preclinical Candidate.
AID1161931Inhibition of human carbonic anhydrase 2 preincubated for 15 mins by stopped flow CO2 hydration method2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Discovery of a new family of carbonic anhydrases in the malaria pathogen Plasmodium falciparum--the η-carbonic anhydrases.
AID1430528Inhibition of Burkholderia pseudomallei recombinant His-tagged carbonic anhydrase beta (256 residues) expressed in Escherichia coli BL21 (DE3) incubated for 15 mins prior to testing by stopped flow CO2 hydration method
AID1243777Mutagenicity in Salmonella typhimurium TA100 assessed as mutagenicity index at 5 ug/plate incubated for 90 mins at 37 degC in absence of liver S9 fractions by Ames test relative to untreated control2015European journal of medicinal chemistry, Aug-28, Volume: 101Leishmanicidal, antiproteolytic, and mutagenic evaluation of alkyltriazoles and alkylphosphocholines.
AID533734Induction of mutagenicity in Salmonella serovar Typhimurium TA 100 assessed as number of revertant colonies at 5 ug by Ames assay2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Novel arylimidamides for treatment of visceral leishmaniasis.
AID569225Inhibition of full-length recombinant HIV1 integrase at 5 ug/ml2011Bioorganic & medicinal chemistry, Feb-01, Volume: 19, Issue:3
Design and synthesis of caffeoyl-anilides as portmanteau inhibitors of HIV-1 integrase and CCR5.
AID1577411Genotoxicity in Salmonella typhimurium TA100 at 30 uM in absence of rat liver S9 fraction by Ames test2019Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
Development of 3,5-Dinitrophenyl-Containing 1,2,4-Triazoles and Their Trifluoromethyl Analogues as Highly Efficient Antitubercular Agents Inhibiting Decaprenylphosphoryl-β-d-ribofuranose 2'-Oxidase.
AID587132Inhibition of Leptonychotes weddellii alpha-carbonic anhydrase after 15 mins by CO2 hydrase assay at pH 7.52011Bioorganic & medicinal chemistry, Mar-15, Volume: 19, Issue:6
Purification and inhibition studies with anions and sulfonamides of an α-carbonic anhydrase from the Antarctic seal Leptonychotes weddellii.
AID1243843Mutagenicity in Salmonella typhimurium TA97a assessed as mutagenicity index at 5 ug/plate incubated for 90 mins at 37 degC in presence of liver S9 fractions by Ames test relative to control2015European journal of medicinal chemistry, Aug-28, Volume: 101Leishmanicidal, antiproteolytic, and mutagenic evaluation of alkyltriazoles and alkylphosphocholines.
AID278886Increase in lactate production in primary human osteoblasts at 1 mM after 1 hr by ELISA2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
AID1329425Induction of ROS generation in Leishmania infantum MHOM/BR/1972/LD promastigote form at 10 mM incubated for 120 mins by H2DCF-DA probe based fluorimetric assay2016Journal of natural products, 09-23, Volume: 79, Issue:9
Analogues of Marine Guanidine Alkaloids Are in Vitro Effective against Trypanosoma cruzi and Selectively Eliminate Leishmania (L.) infantum Intracellular Amastigotes.
AID763566Inhibition of Brucella suis beta carbonic anhydrase-2 at 20 degC by stopped-flow CO2 hydrase assay2013Bioorganic & medicinal chemistry, Aug-01, Volume: 21, Issue:15
Anion inhibition studies of the α-carbonic anhydrase from the protozoan pathogen Trypanosoma cruzi, the causative agent of Chagas disease.
AID724722Inhibition of human recombinant wild type CA1 by stopped-flow CO2 hydration method2013Bioorganic & medicinal chemistry letters, Jan-01, Volume: 23, Issue:1
Restoring catalytic activity to the human carbonic anhydrase (CA) related proteins VIII, X and XI affords isoforms with high catalytic efficiency and susceptibility to anion inhibition.
AID1265551Mutagenicity in Salmonella typhimurium TA100 assessed as number of revertants at 5 ug/plate by Ames test (Rvb = 77 +/-4 No_unit)2016European journal of medicinal chemistry, Jan-01, Volume: 107Anticonvulsant activity, crystal structures, and preliminary safety evaluation of N-trans-cinnamoyl derivatives of selected (un)modified aminoalkanols.
AID1430526Inhibition of recombinant human carbonic anhydrase 2 assessed as inhibition of CO2 hydration incubated for 15 mins prior to testing by stopped flow CO2 hydration method
AID1058395Inhibition of human cytosolic carbonic anhydrase 2 preincubated for 15 mins by stopped flow CO2 hydration assay2013Bioorganic & medicinal chemistry letters, Dec-15, Volume: 23, Issue:24
Anion inhibition studies of a β-carbonic anhydrase from Clostridium perfringens.
AID730372Inhibition of Flaveria bidentis beta-carbonic anhydrase-1 preincubated for 15 mins by stopped flow CO2 hydration assay2013Bioorganic & medicinal chemistry letters, Mar-15, Volume: 23, Issue:6
Kinetic and anion inhibition studies of a β-carbonic anhydrase (FbiCA 1) from the C4 plant Flaveria bidentis.
AID1336557Inhibition of human recombinant carbonic anhydrase 2 assessed as inhibition of CO2 hydration preincubated for 15 mins by Lineweaver-burk plot method
AID1241893Genotoxicity in Salmonella typhimurium TA100 assessed as induction of revertant colonies at 1 ug/plate in absence of S9 mix by Ames test relative untreated control2015European journal of medicinal chemistry, Aug-28, Volume: 101Novel benzidine and diaminofluorene prolinamide derivatives as potent hepatitis C virus NS5A inhibitors.
AID1336558Inhibition of Methanosarcina thermophila recombinant carbonic anhydrase gamma assessed as inhibition of CO2 hydration preincubated for 15 mins by Lineweaver-burk plot method
AID677270Inhibition of Sulfurihydrogenibium yellowstonense YO3AOP1 alpha-carbonic anhydrase-catalyzed CO2 hydration reaction preincubated for 15 mins by stopped flow CO2 hydrase assay2012Bioorganic & medicinal chemistry letters, Sep-01, Volume: 22, Issue:17
Anion inhibition studies of an α-carbonic anhydrase from the thermophilic bacterium Sulfurihydrogenibium yellowstonense YO3AOP1.
AID69151Compound was tested for its ability to inhibit DNA strand scission induced by resveratrol and Cu2+, at concentration 50 mM1998Bioorganic & medicinal chemistry letters, Nov-17, Volume: 8, Issue:22
Resveratrol as a new type of DNA-cleaving agent.
AID1459078Mutagenicity in Salmonella typhimurium TA100 assessed as revertant colonies/plate in absence of liver S9 fraction at 1 ug/plate by Ames test (Rvb = 125 +/- 9 No_unit)2017European journal of medicinal chemistry, Jan-05, Volume: 125New potent biaryl sulfate-based hepatitis C virus inhibitors.
AID714403Inhibition of Sulfurihydrogenibium azorense alpha-carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration assay2012Bioorganic & medicinal chemistry letters, Dec-01, Volume: 22, Issue:23
Anion inhibition studies of the fastest carbonic anhydrase (CA) known, the extremo-CA from the bacterium Sulfurihydrogenibium azorense.
AID730751Inhibition of Vibrio cholerae alpha carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration assay2013Bioorganic & medicinal chemistry letters, Mar-15, Volume: 23, Issue:6
Anion inhibition studies of the α-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae.
AID552168Inhibition of human carbonic anhydrase 9 by Lineweaver-Burk curves2011Bioorganic & medicinal chemistry, Jan-15, Volume: 19, Issue:2
Characterization and anions inhibition studies of an α-carbonic anhydrase from the teleost fish Dicentrarchus labrax.
AID758952Inhibition of human recombinant CA2 by CO2 hydration assay2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
A highly catalytically active γ-carbonic anhydrase from the pathogenic anaerobe Porphyromonas gingivalis and its inhibition profile with anions and small molecules.
AID598726Inhibition of recombinant human carbonic anhydrase 1 after 15 mins by stopped flow CO2 hydration assay at pH 8.32011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
Inhibition studies with anions and small molecules of two novel β-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium.
AID1070021Inhibition of Legionella pneumophila carbonic anhydrase 2 preincubated for 15 mins by stopped-flow CO2 hydrase assay2014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Anion inhibition studies of two new β-carbonic anhydrases from the bacterial pathogen Legionella pneumophila.
AID1201519Mutagenicity in Salmonella typhimurium TA100 at 2.5 mM after 1 hr by Ames test in absence of S9 fraction2015European journal of medicinal chemistry, May-05, Volume: 95Discovery of new thienopyrimidinone derivatives displaying antimalarial properties toward both erythrocytic and hepatic stages of Plasmodium.
AID628706Inhibition of Trametes versicolor laccase assessed as production of dopachrome using 100 uM epinephrine as substrate preincubated for 30 mins before substrate addition2011Bioorganic & medicinal chemistry, Nov-15, Volume: 19, Issue:22
Ptilomycalin A inhibits laccase and melanization in Cryptococcus neoformans.
AID1457250Genotoxicity in Salmonella typhimurium TA100 assessed as number of revertants per plate at 1 ug/plate in absence of rat liver S9 fraction by Ames test (Rvb = 154 +/- 9 No_unit)2017Journal of medicinal chemistry, 07-13, Volume: 60, Issue:13
Benzoxaborole Antimalarial Agents. Part 5. Lead Optimization of Novel Amide Pyrazinyloxy Benzoxaboroles and Identification of a Preclinical Candidate.
AID1237477Inhibition of Pseudomonas aeruginosa PAO1 type-2 beta-carbonic anhydrase psCA3 expressed in Escherichia coli Tuner BL21 (DE3) cells pre-incubated for 15 mins at pH 8.3 and 293K by CO2 hydration reaction based colorimetric stopped-flow method2015Bioorganic & medicinal chemistry, Aug-01, Volume: 23, Issue:15
Structure and inhibition studies of a type II beta-carbonic anhydrase psCA3 from Pseudomonas aeruginosa.
AID763569Inhibition of human carbonic anhydrase-1 at 20 degC preincubated for 15 mins by stopped-flow CO2 hydrase assay2013Bioorganic & medicinal chemistry, Aug-01, Volume: 21, Issue:15
Anion inhibition studies of the α-carbonic anhydrase from the protozoan pathogen Trypanosoma cruzi, the causative agent of Chagas disease.
AID552171Inhibition of human carbonic anhydrase 1 by Lineweaver-Burk curves2011Bioorganic & medicinal chemistry, Jan-15, Volume: 19, Issue:2
Characterization and anions inhibition studies of an α-carbonic anhydrase from the teleost fish Dicentrarchus labrax.
AID730368Inhibition of Helicobacter pylori beta-carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration assay2013Bioorganic & medicinal chemistry letters, Mar-15, Volume: 23, Issue:6
Kinetic and anion inhibition studies of a β-carbonic anhydrase (FbiCA 1) from the C4 plant Flaveria bidentis.
AID1269931Inhibition of Colwellia psychrerythraea gamma carbonic anhydrase expressed in Escherichia coli incubated for 15 mins prior to testing by stopped flow CO2 hydration method2016Bioorganic & medicinal chemistry, Feb-15, Volume: 24, Issue:4
Cloning, characterization and anion inhibition studies of a γ-carbonic anhydrase from the Antarctic bacterium Colwellia psychrerythraea.
AID323191Protection against 30 mins photoirradiation-induced lipid peroxidation damage in rat liver mitochondria assessed as prevention of TBARS formation at 10 mM2008Bioorganic & medicinal chemistry, Mar-15, Volume: 16, Issue:6
Inhibitory property of the Piper betel phenolics against photosensitization-induced biological damages.
AID714400Inhibition of human cytosolic carbonic anhydrase 2 preincubated for 15 mins by stopped flow CO2 hydration assay2012Bioorganic & medicinal chemistry letters, Dec-01, Volume: 22, Issue:23
Anion inhibition studies of the fastest carbonic anhydrase (CA) known, the extremo-CA from the bacterium Sulfurihydrogenibium azorense.
AID1237475Inhibition of human carbonic anhydrase-2 by CO2 hydration reaction based colorimetric stopped-flow method2015Bioorganic & medicinal chemistry, Aug-01, Volume: 23, Issue:15
Structure and inhibition studies of a type II beta-carbonic anhydrase psCA3 from Pseudomonas aeruginosa.
AID552170Inhibition of Dicentrarchus labrax alpha-carbonic anhydrase by Lineweaver-Burk curves2011Bioorganic & medicinal chemistry, Jan-15, Volume: 19, Issue:2
Characterization and anions inhibition studies of an α-carbonic anhydrase from the teleost fish Dicentrarchus labrax.
AID1329424Induction of mitochondrial membrane potential loss in Leishmania infantum MHOM/BR/1972/LD promastigote form at 10 mM incubated for 60 mins by rhodamine-123 dye based fluorimetric assay2016Journal of natural products, 09-23, Volume: 79, Issue:9
Analogues of Marine Guanidine Alkaloids Are in Vitro Effective against Trypanosoma cruzi and Selectively Eliminate Leishmania (L.) infantum Intracellular Amastigotes.
AID465486Mutagenic activity in Salmonella typhimurium TA100 assessed as increase in number of revertants at 5 ug/plate by Ames test absence of S9 fraction (Rvb=108+/-5)2010Journal of natural products, Feb-26, Volume: 73, Issue:2
DNA-damaging, mutagenic, and clastogenic activities of gentiopicroside isolated from Cephalaria kotschyi roots.
AID1201518Mutagenicity in Salmonella typhimurium TA97A at 2.5 mM after 1 hr by Ames test in absence of S9 fraction2015European journal of medicinal chemistry, May-05, Volume: 95Discovery of new thienopyrimidinone derivatives displaying antimalarial properties toward both erythrocytic and hepatic stages of Plasmodium.
AID1296412Mutagenic activity in Salmonella typhimurium TA98 assessed as reverse mutation at 30 uM by Ames test2016Journal of medicinal chemistry, Mar-24, Volume: 59, Issue:6
Development of 3,5-Dinitrobenzylsulfanyl-1,3,4-oxadiazoles and Thiadiazoles as Selective Antitubercular Agents Active Against Replicating and Nonreplicating Mycobacterium tuberculosis.
AID724720Inhibition of human recombinant CA8 mutant after 15 mins by stopped-flow CO2 hydration method2013Bioorganic & medicinal chemistry letters, Jan-01, Volume: 23, Issue:1
Restoring catalytic activity to the human carbonic anhydrase (CA) related proteins VIII, X and XI affords isoforms with high catalytic efficiency and susceptibility to anion inhibition.
AID1070020Inhibition of human carbonic anhydrase 2 by stopped-flow CO2 hydrase assay2014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Anion inhibition studies of two new β-carbonic anhydrases from the bacterial pathogen Legionella pneumophila.
AID647373Inhibition of Astrosclera willeyana recombinant GST-tagged astrosclerin 3 expressed in Escherichia coli BL21-DE3-RIPL cells preincubated for 15 mins measured for 10 to 100 secs by stopped flow CO2 hydration assay2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
Anion inhibition studies of an α-carbonic anhydrase from the living fossil Astrosclera willeyana.
AID758950Inhibition of Methanosarcina thermophila recombinant gamma-CA by CO2 hydration assay2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
A highly catalytically active γ-carbonic anhydrase from the pathogenic anaerobe Porphyromonas gingivalis and its inhibition profile with anions and small molecules.
AID628707Inhibition of laccase in Cryptococcus neoformans var. grubii assessed as production of dopachrome using 100 uM epinephrine as substrate preincubated for 30 mins before substrate addition2011Bioorganic & medicinal chemistry, Nov-15, Volume: 19, Issue:22
Ptilomycalin A inhibits laccase and melanization in Cryptococcus neoformans.
AID278870Increase in lactate production in primary human osteoblasts by ELISA relative to control2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
AID724719Inhibition of human recombinant CA10 mutant after 15 mins by stopped-flow CO2 hydration method2013Bioorganic & medicinal chemistry letters, Jan-01, Volume: 23, Issue:1
Restoring catalytic activity to the human carbonic anhydrase (CA) related proteins VIII, X and XI affords isoforms with high catalytic efficiency and susceptibility to anion inhibition.
AID569226Inhibition of full-length recombinant HIV1 integrase2011Bioorganic & medicinal chemistry, Feb-01, Volume: 19, Issue:3
Design and synthesis of caffeoyl-anilides as portmanteau inhibitors of HIV-1 integrase and CCR5.
AID1430527Inhibition of Burkholderia pseudomallei recombinant carbonic anhydrase gamma incubated for 15 mins prior to testing by stopped flow CO2 hydration method
AID1161952Inhibition of Porphyromonas gingivalis beta-carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration method2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Anion inhibition study of the β-class carbonic anhydrase (PgiCAb) from the oral pathogen Porphyromonas gingivalis.
AID724718Inhibition of human recombinant CA11 mutant after 15 mins by stopped-flow CO2 hydration method2013Bioorganic & medicinal chemistry letters, Jan-01, Volume: 23, Issue:1
Restoring catalytic activity to the human carbonic anhydrase (CA) related proteins VIII, X and XI affords isoforms with high catalytic efficiency and susceptibility to anion inhibition.
AID1336562Inhibition of Burkholderia pseudomallei recombinant His-tagged carbonic anhydrase gamma expressed in Escherichia coli BL21 (DE3) assessed as inhibition of CO2 hydration preincubated for 15 mins by Lineweaver-burk plot method
AID1336560Inhibition of Nostoc commune recombinant carbonic anhydrase gamma assessed as inhibition of CO2 hydration preincubated for 15 mins by Lineweaver-burk plot method
AID1161950Inhibition of human carbonic anhydrase 2 preincubated for 15 mins by stopped flow CO2 hydration method2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Anion inhibition study of the β-class carbonic anhydrase (PgiCAb) from the oral pathogen Porphyromonas gingivalis.
AID730753Inhibition of human carbonic anhydrase 2 preincubated for 15 mins by stopped flow CO2 hydration assay2013Bioorganic & medicinal chemistry letters, Mar-15, Volume: 23, Issue:6
Anion inhibition studies of the α-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (1,917)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990483 (25.20)18.7374
1990's523 (27.28)18.2507
2000's549 (28.64)29.6817
2010's324 (16.90)24.3611
2020's38 (1.98)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 85.27

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index85.27 (24.57)
Research Supply Index7.61 (2.92)
Research Growth Index4.44 (4.65)
Search Engine Demand Index156.25 (26.88)
Search Engine Supply Index2.01 (0.95)

This Compound (85.27)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials5 (0.25%)5.53%
Reviews21 (1.04%)6.00%
Case Studies33 (1.64%)4.05%
Observational0 (0.00%)0.25%
Other1,959 (97.08%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]